Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Brito-Sousa JD. et al, (2021), PLoS Negl Trop Dis, 15
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
Bancone G. and Chu CS., (2021), Frontiers in Pharmacology, 12
Vivax malaria in pregnancy and lactation: a long way to health equity
Brummaier T. et al, (2020), Malaria Journal, 19
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency
Schilling WHK. et al, (2020), Blood Cells, Molecules, and Diseases, 85, 102484 - 102484
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Pfeffer DA. et al, (2020), PLOS Medicine, 17, e1003084 - e1003084
Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter.
Chu CS. et al, (2020), Wellcome open research, 5
Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
Ley B. et al, (2019), PLOS Medicine, 16, e1002992 - e1002992
Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion
Bancone G. et al, (2019), Malaria Journal, 18
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
Chu CS. et al, (2019), Wellcome Open Research, 4, 25 - 25
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Chu CS. et al, (2019), Clinical Infectious Diseases, 68, 1311 - 1319
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
Chu CS. et al, (2019), Wellcome Open Research, 4, 25 - 25
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient
Pal S. et al, (2019), The American Journal of Tropical Medicine and Hygiene, 100, 213 - 221
A POTENTIALLY SAFER RADICAL CURE REGIMEN OF PRIMAQUINE - EARLY RESULTS FROM A PRIMAQUINE CHALLENGE STUDY IN HEALTHY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENT MALES
Jittamala P. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 486 - 487
Evaluation of a treatment protocol for anaemia in pregnancy nested in routine antenatal care in a limited-resource setting
Gilder ME. et al, (2019), Global Health Action, 12, 1621589 - 1621589
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Llanos-Cuentas A. et al, (2019), The New England journal of medicine, 380, 229 - 241
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
Chu CS. et al, (2019), Wellcome open research, 4
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
Chu CS. et al, (2018), Malaria Journal, 17
Laboratory validation and field usability assessment of a point-of-care test for serum bilirubin levels in neonates in a tropical setting
Thielemans L. et al, (2018), Wellcome Open Research, 3, 110 - 110
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
Chu CS. et al, (2018), Clinical Infectious Diseases, 67, 1543 - 1549